Research Education Core
研究教育核心
基本信息
- 批准号:10684071
- 负责人:
- 金额:$ 13.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAcuteAddressAnimal Disease ModelsAreaBasic ScienceBiometryChronicClinical TrialsCommunitiesComplexDevelopmentDiverse WorkforceDrug ScreeningEducational ActivitiesEducational workshopEffectivenessEmergency responseEnvironmentEvaluationExposure toFacultyFeedbackFosteringFutureGenerationsGoalsGovernmentGrowthHuman ResourcesImageIndustryInnovative TherapyInstitutionInterdisciplinary StudyIntoxicationKnowledgeLaboratoriesLearningMedical StudentsMentorsMissionNeurologicNeurologyNeurosciencesOrganophosphatesOutcomeParticipantPatientsPharmaceutical ChemistryPharmacologyPharmacology and ToxicologyPostdoctoral FellowPreclinical TestingProcessResearchResearch ActivityResearch PersonnelResearch Project SummariesResearch TrainingResourcesScientistTherapeuticToxicologyTrainingTranslational ResearchUnderrepresented PopulationsUnited States National Institutes of HealthWorkcareerchemical threatcohortdesigndisadvantaged backgrounddrug developmentdrug discoveryeducation researcheffectiveness evaluationemergency preparednessequity, diversity, and inclusionexperiencegraduate studentimprovedinstructorlecturesmedical countermeasuremeetingsmembernervous system disorderneurotoxicologynext generationoutreachprogramsrecruitresponsible research conductrole modelskillssocioeconomic disadvantagesuccessundergraduate student
项目摘要
Project Summary – Research Education Core (REC)
The training of future leaders in the development of medical countermeasures for chemical threat agents is
critical to the success of the CounterACT program and to national emergency response and preparedness
efforts. The overall mission of the Research Education Core (REC) is to create a diverse array of human
resources capable of conducting team-based interdisciplinary research focused on addressing the complex
problems posed by chemical threat agents. Advanced training in pharmacology, toxicology, neuroscience, and
drug discovery will be provided to a diverse generation of researchers, more specifically, technicians, medical
and graduate students, postdoctoral fellows, and/or early stage investigators within and outside the UC Davis
CounterACT Center. Accordingly, the REC will interact with all Cores and Projects of the Center. A major
emphasis will be enhancing the diversity, and recruitment of trainees and mentors from underrepresented and
socioeconomically disadvantaged backgrounds into the Center.
The educational research environment at UC Davis is well suited for the CounterACT Center. UC Davis is a
national leader in pharmacology and toxicology, and CounterACT faculty have expertise in fundamental
pharmacology, toxicology, medicinal chemistry, drug screening, mechanistic target identification, animal models
of disease, advanced imaging, biostatistics as well as preclinical testing and participation in clinical trials. The
REC will facilitate the transfer of this knowledge to trainees and promote the advancement of trainees’ careers
by providing opportunities to be mentored by and learn from both internal and external scientists with expertise
relevant to the CounterACT mission.
The REC has three main objectives: (1) Develop skill sets necessary for the study of toxicology, pharmacology,
drug discovery, neuroscience, and neurological disorders related to chemical threat agents. First, hands-
on interdisciplinary and collaborative research training primarily in the laboratories of the Project and Core
Leaders will be provided. Second, specialized didactic training in areas relevant to the Center’s mission will be
accomplished via workshops, seminars, and specialized coursework. (2) Enhance the recruitment of graduate
students and faculty from underrepresented backgrounds into the UC Davis CounterACT Center by leveraging
well established undergraduate, graduate, and faculty STEM-related recruiting and retention programs on
campus. (3) Evaluate the activities of the REC to assess effectiveness and identify areas for improvement.
By fulfilling these objectives, the REC will accomplish its goal of developing a diverse group of scientists with
broader understanding of the concepts, challenges, and opportunities in drug discovery and development of
medical countermeasures of chemical threat agents.
项目摘要-研究教育核心(REC)
培养未来的领导者,制定针对化学威胁剂的医疗对策,
这对反ACT计划的成功以及国家应急响应和准备至关重要
努力研究教育核心(REC)的总体使命是创造一个多样化的人类
资源能够进行基于团队的跨学科研究,重点是解决复杂的
化学威胁剂带来的问题。药理学、毒理学、神经科学和
药物发现将提供给不同一代的研究人员,更具体地说,技术人员,医疗
研究生,博士后研究员和/或加州大学戴维斯分校内外的早期研究人员
反ACT中心。因此,REC将与中心的所有核心和项目进行互动。一个主要
重点将是加强多样性,从代表性不足的国家和地区征聘受训人员和导师,
社会经济背景的弱势群体进入中心。
加州大学戴维斯分校的教育研究环境非常适合反ACT中心。加州大学戴维斯分校是一个
药理学和毒理学的国家领导者,以及CounterACT教师在基础方面的专业知识
药理学、毒理学、药物化学、药物筛选、机制靶点鉴定、动物模型
疾病、先进成像、生物统计学以及临床前测试和参与临床试验。的
资源中心将协助学员学习这些知识,并促进学员的职业发展
通过提供机会,接受内部和外部具有专业知识的科学家的指导和学习,
与反恐行动使命有关
REC有三个主要目标:(1)发展毒理学,药理学,
药物发现、神经科学和与化学威胁剂有关的神经系统疾病。首先,手-
主要在项目和核心实验室进行跨学科和合作研究培训
将提供领导人。第二,在与中心的使命有关的领域进行专门的教学培训,
通过讲习班、研讨会和专业课程完成。(2)加强毕业生招聘
来自代表性不足背景的学生和教师进入加州大学戴维斯分校CounterACT中心,
完善的本科生,研究生和教师STEM相关的招聘和保留计划,
校园(3)评估REC的活动,以评估有效性并确定需要改进的领域。
通过实现这些目标,区域环境中心将实现其发展多样化科学家群体的目标,
更广泛地了解药物发现和开发的概念,挑战和机遇,
化学威胁剂的医学对策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gene Gabriel Gurkoff其他文献
Gene Gabriel Gurkoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gene Gabriel Gurkoff', 18)}}的其他基金
Project 3: Normalization of Neuronal Excitability
项目 3:神经元兴奋性正常化
- 批准号:
10684091 - 财政年份:2022
- 资助金额:
$ 13.6万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 13.6万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 13.6万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 13.6万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 13.6万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 13.6万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 13.6万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 13.6万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 13.6万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 13.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 13.6万 - 项目类别:
Operating Grants